INDUSTRY OVERVIEW
The Point-of-Care Biopsy is Growing at 9% and is expected to reach 2.5Billion by 2032. Below mentioned are some of the dynamics shaping the Point-of-Care Biopsy.Point-of-Care Biopsy Market Size in (USD Billion) CAGR Growth Rate 9%
| Study Period | 2020-2032 |
| Market Size (2024): | 1.1Billion |
| Market Size (2032): | 2.5Billion |
| CAGR (2024 - 2032): | 9% |
| Fastest Growing Region | Asia-Pacific |
| Dominating Region | North America |
www.www.htfmarketinsights.com
Point-of-care biopsy refers to minimally invasive tissue sampling methods that can be performed rapidly near the patient site without need for centralized labs. Techniques include fine needle aspiration, core biopsy, and liquid biopsy. These allow faster diagnosis and treatment decisions especially in oncology and infectious diseases, improving patient outcomes and reducing hospital stay and costs. Advances in imaging and molecular analysis have expanded their utility and accuracy.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Regulatory Landscape
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Demand For Rapid Diagnostics
- Increasing Cancer Incidence
- Technological Innovations
- Decentralized Healthcare
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- Sample Quality Issues
- Operator Skill Requirements
- Regulatory Compliance
- Cost
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Integration with molecular diagnostics
- AI-assisted imaging
- Portable biopsy devices
- Minimally invasive techniques
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Expansion In Emerging Markets
- Home Care Diagnostics
- AI Diagnostic Tools
- Workflow Automation
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- Needle biopsy
- Core biopsy
- Fine needle aspiration
- Liquid biopsy
Point-of-Care Biopsy Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Cancer diagnosis
- Infectious disease detection
- Pathology
- Personalized medicine
- Surgical planning
Point-of-Care Biopsy Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The North America currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, Asia-Pacific is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
Asia-Pacific
Dominating Region
North America
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- Thermo Fisher Scientific (USA)
- Leica Biosystems (Germany)
- Hologic (USA)
- Becton Dickinson (USA)
- GE Healthcare (USA)
- Roche Diagnostics (Switzerland)
- Philips Healthcare (Netherlands)
- Siemens Healthineers (Germany)
- Qiagen (Germany)
- Agilent Technologies (USA)
- Danaher Corporation (USA)
- Sysmex Corporation (Japan)
- Bio-Rad Laboratories (USA)
- Bruker Corporation (USA)
Point-of-Care Biopsy Market Segmentation by Players
www.htfmarketinsights.com
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2024 |
|
Based Year Market Size (2023) |
1.1Billion |
|
Historical Period |
2020 to 2024 |
|
CAGR (2024 to 2032) |
9% |
|
Forecast Period |
2024 to 2032 |
|
Forecasted Period Market Size (2032) |
2.5Billion |
|
Scope of the Report |
Segmentation by Type
Segmentation by Application
|
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
Thermo Fisher Scientific (USA), Leica Biosystems (Germany), Hologic (USA), Becton Dickinson (USA), GE Healthcare (USA), Roche Diagnostics (Switzerland), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Qiagen (Germany), Agilent Technologies (USA), Danaher Corporation (USA), Sysmex Corporation (Japan), Bio-Rad Laboratories (USA), Bruker Corporation (USA) |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Point-of-Care Biopsy - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Point-of-Care Biopsy Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Point-of-Care Biopsy Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Point-of-Care Biopsy Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Demand for rapid diagnostics
- 3.1.2 Increasing cancer incidence
- 3.1.3 Technological innovations
- 3.1.4 Decentralized healthcare
-
3.2 Available Opportunities
- 3.2.1 Expansion in emerging markets
- 3.2.2 Home care diagnostics
- 3.2.3 AI diagnostic tools
- 3.2.4 Workflow
-
3.3 Influencing Trends
- 3.3.1 Integration with molecular diagnostics
- 3.3.2 AI-assisted imaging
- 3.3.3 Portable biopsy devices
-
3.4 Challenges
- 3.4.1 Sample quality issues
- 3.4.2 Operator skill requirements
- 3.4.3 Regulatory compliance
- 3.4.4 Cost
- 3.4.5 Pat
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Point-of-Care Biopsy Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Point-of-Care Biopsy Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Point-of-Care Biopsy : Competition Benchmarking & Performance Evaluation
- 5.1 Global Point-of-Care Biopsy Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Point-of-Care Biopsy Revenue 2024
- 5.3 Global Point-of-Care Biopsy Sales Volume by Manufacturers (2024)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 Ansoff Matrix
- 5.6 FPNV Positioning Matrix
Chapter 6: Global Point-of-Care Biopsy Market: Company Profiles
- 6.1 Thermo Fisher Scientific (USA)
- 6.1.1 Thermo Fisher Scientific (USA) Company Overview
- 6.1.2 Thermo Fisher Scientific (USA) Product/Service Portfolio & Specifications
- 6.1.3 Thermo Fisher Scientific (USA) Key Financial Metrics
- 6.1.4 Thermo Fisher Scientific (USA) SWOT Analysis
- 6.1.5 Thermo Fisher Scientific (USA) Development Activities
- 6.2 Leica Biosystems (Germany)
- 6.3 Hologic (USA)
- 6.4 Becton Dickinson (USA)
- 6.5 GE Healthcare (USA)
- 6.6 Roche Diagnostics (Switzerland)
- 6.7 Philips Healthcare (Netherlands)
- 6.8 Siemens Healthineers (Germany)
- 6.9 Qiagen (Germany)
- 6.10 Agilent Technologies (USA)
- 6.11 Danaher Corporation (USA)
- 6.12 Sysmex Corporation (Japan)
- 6.13 Bio-Rad Laboratories (USA)
- 6.14 Bruker Corporation (USA)
- 6.15 Illumina (USA)
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Point-of-Care Biopsy by Type & Application (2020-2032)
-
7.1 Global Point-of-Care Biopsy Market Revenue Analysis (USD Million) by Type (2020-2024)
- 7.1.1 Needle Biopsy
- 7.1.2 Core Biopsy
- 7.1.3 Fine Needle Aspiration
- 7.1.4 Liquid Biopsy
- 7.1.5 Image-guided Biopsy
-
7.2 Global Point-of-Care Biopsy Market Revenue Analysis (USD Million) by Application (2020-2024)
- 7.2.1 Cancer Diagnosis
- 7.2.2 Infectious Disease Detection
- 7.2.3 Pathology
- 7.2.4 Personalized Medicine
- 7.2.5 Surgical Planning
- 7.3 Global Point-of-Care Biopsy Market Revenue Analysis (USD Million) by Type (2024-2032)
- 7.4 Global Point-of-Care Biopsy Market Revenue Analysis (USD Million) by Application (2024-2032)
Chapter 8 : North America Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 8.1 North America Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 8.2.1 Needle Biopsy
- 8.2.2 Core Biopsy
- 8.2.3 Fine Needle Aspiration
- 8.2.4 Liquid Biopsy
- 8.2.5 Image-guided Biopsy
-
8.3 North America Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 8.3.1 Cancer Diagnosis
- 8.3.2 Infectious Disease Detection
- 8.3.3 Pathology
- 8.3.4 Personalized Medicine
- 8.3.5 Surgical Planning
- 8.4 North America Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 8.5 North America Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 8.6 North America Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 9.1 LATAM Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 9.2.1 Needle Biopsy
- 9.2.2 Core Biopsy
- 9.2.3 Fine Needle Aspiration
- 9.2.4 Liquid Biopsy
- 9.2.5 Image-guided Biopsy
-
9.3 LATAM Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 9.3.1 Cancer Diagnosis
- 9.3.2 Infectious Disease Detection
- 9.3.3 Pathology
- 9.3.4 Personalized Medicine
- 9.3.5 Surgical Planning
- 9.4 LATAM Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 9.5 LATAM Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 9.6 LATAM Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 10 : West Europe Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 10.1 West Europe Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 10.2.1 Needle Biopsy
- 10.2.2 Core Biopsy
- 10.2.3 Fine Needle Aspiration
- 10.2.4 Liquid Biopsy
- 10.2.5 Image-guided Biopsy
-
10.3 West Europe Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 10.3.1 Cancer Diagnosis
- 10.3.2 Infectious Disease Detection
- 10.3.3 Pathology
- 10.3.4 Personalized Medicine
- 10.3.5 Surgical Planning
- 10.4 West Europe Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 10.5 West Europe Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 10.6 West Europe Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 11 : Central & Eastern Europe Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 11.2.1 Needle Biopsy
- 11.2.2 Core Biopsy
- 11.2.3 Fine Needle Aspiration
- 11.2.4 Liquid Biopsy
- 11.2.5 Image-guided Biopsy
-
11.3 Central & Eastern Europe Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 11.3.1 Cancer Diagnosis
- 11.3.2 Infectious Disease Detection
- 11.3.3 Pathology
- 11.3.4 Personalized Medicine
- 11.3.5 Surgical Planning
- 11.4 Central & Eastern Europe Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 11.5 Central & Eastern Europe Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 11.6 Central & Eastern Europe Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 12 : Northern Europe Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 12.2.1 Needle Biopsy
- 12.2.2 Core Biopsy
- 12.2.3 Fine Needle Aspiration
- 12.2.4 Liquid Biopsy
- 12.2.5 Image-guided Biopsy
-
12.3 Northern Europe Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 12.3.1 Cancer Diagnosis
- 12.3.2 Infectious Disease Detection
- 12.3.3 Pathology
- 12.3.4 Personalized Medicine
- 12.3.5 Surgical Planning
- 12.4 Northern Europe Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 12.5 Northern Europe Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 12.6 Northern Europe Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 13 : Southern Europe Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 13.2.1 Needle Biopsy
- 13.2.2 Core Biopsy
- 13.2.3 Fine Needle Aspiration
- 13.2.4 Liquid Biopsy
- 13.2.5 Image-guided Biopsy
-
13.3 Southern Europe Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 13.3.1 Cancer Diagnosis
- 13.3.2 Infectious Disease Detection
- 13.3.3 Pathology
- 13.3.4 Personalized Medicine
- 13.3.5 Surgical Planning
- 13.4 Southern Europe Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 13.5 Southern Europe Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 13.6 Southern Europe Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 14 : East Asia Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 14.1 East Asia Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 14.2.1 Needle Biopsy
- 14.2.2 Core Biopsy
- 14.2.3 Fine Needle Aspiration
- 14.2.4 Liquid Biopsy
- 14.2.5 Image-guided Biopsy
-
14.3 East Asia Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 14.3.1 Cancer Diagnosis
- 14.3.2 Infectious Disease Detection
- 14.3.3 Pathology
- 14.3.4 Personalized Medicine
- 14.3.5 Surgical Planning
- 14.4 East Asia Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 14.5 East Asia Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 14.6 East Asia Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 15 : Southeast Asia Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 15.2.1 Needle Biopsy
- 15.2.2 Core Biopsy
- 15.2.3 Fine Needle Aspiration
- 15.2.4 Liquid Biopsy
- 15.2.5 Image-guided Biopsy
-
15.3 Southeast Asia Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 15.3.1 Cancer Diagnosis
- 15.3.2 Infectious Disease Detection
- 15.3.3 Pathology
- 15.3.4 Personalized Medicine
- 15.3.5 Surgical Planning
- 15.4 Southeast Asia Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 15.5 Southeast Asia Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 15.6 Southeast Asia Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 16 : South Asia Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 16.1 South Asia Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 16.2.1 Needle Biopsy
- 16.2.2 Core Biopsy
- 16.2.3 Fine Needle Aspiration
- 16.2.4 Liquid Biopsy
- 16.2.5 Image-guided Biopsy
-
16.3 South Asia Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 16.3.1 Cancer Diagnosis
- 16.3.2 Infectious Disease Detection
- 16.3.3 Pathology
- 16.3.4 Personalized Medicine
- 16.3.5 Surgical Planning
- 16.4 South Asia Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 16.5 South Asia Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 16.6 South Asia Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 17 : Central Asia Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 17.1 Central Asia Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 17.2.1 Needle Biopsy
- 17.2.2 Core Biopsy
- 17.2.3 Fine Needle Aspiration
- 17.2.4 Liquid Biopsy
- 17.2.5 Image-guided Biopsy
-
17.3 Central Asia Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 17.3.1 Cancer Diagnosis
- 17.3.2 Infectious Disease Detection
- 17.3.3 Pathology
- 17.3.4 Personalized Medicine
- 17.3.5 Surgical Planning
- 17.4 Central Asia Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 17.5 Central Asia Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 17.6 Central Asia Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 18 : Oceania Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 18.1 Oceania Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 18.2.1 Needle Biopsy
- 18.2.2 Core Biopsy
- 18.2.3 Fine Needle Aspiration
- 18.2.4 Liquid Biopsy
- 18.2.5 Image-guided Biopsy
-
18.3 Oceania Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 18.3.1 Cancer Diagnosis
- 18.3.2 Infectious Disease Detection
- 18.3.3 Pathology
- 18.3.4 Personalized Medicine
- 18.3.5 Surgical Planning
- 18.4 Oceania Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 18.5 Oceania Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 18.6 Oceania Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 19 : MEA Point-of-Care Biopsy Market Breakdown by Country, Type & Application
- 19.1 MEA Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 19.2.1 Needle Biopsy
- 19.2.2 Core Biopsy
- 19.2.3 Fine Needle Aspiration
- 19.2.4 Liquid Biopsy
- 19.2.5 Image-guided Biopsy
-
19.3 MEA Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 19.3.1 Cancer Diagnosis
- 19.3.2 Infectious Disease Detection
- 19.3.3 Pathology
- 19.3.4 Personalized Medicine
- 19.3.5 Surgical Planning
- 19.4 MEA Point-of-Care Biopsy Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 19.5 MEA Point-of-Care Biopsy Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 19.6 MEA Point-of-Care Biopsy Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Point-of-Care Biopsy market is estimated to derive a market size of 2.5 Billion by 2032.
According to the report,the Point-of-Care Biopsy Industry size is projected to reach 2.5 Billion, exhibiting a CAGR of 9% by 2032.
The changing dynamics and trends such as Integration With Molecular Diagnostics, AI-assisted Imaging, Portable Biopsy Devices, Minimally Invasive Techniques, Digital Pathology are seen as major Game Changer in Global Point-of-Care Biopsy Market.
The leaders in the Global Point-of-Care Biopsy Market such as Thermo Fisher Scientific (USA), Leica Biosystems (Germany), Hologic (USA), Becton Dickinson (USA), GE Healthcare (USA), Roche Diagnostics (Switzerland), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Qiagen (Germany), Agilent Technologies (USA), Danaher Corporation (USA), Sysmex Corporation (Japan), Bio-Rad Laboratories (USA), Bruker Corporation (USA), Illumina (USA) are targeting innovative and differentiated growth drivers some of them are Demand For Rapid Diagnostics, Increasing Cancer Incidence, Technological Innovations, Decentralized Healthcare, Personalized Treatment
As Industry players prepare to scale up, Point-of-Care Biopsy Market sees major concern such as Sample Quality Issues, Operator Skill Requirements, Regulatory Compliance, Cost, Patient Acceptance.
The market opportunity is clear from the flow of investment into Global Point-of-Care Biopsy Market, some of them are Expansion In Emerging Markets, Home Care Diagnostics, AI Diagnostic Tools, Workflow Automation, Clinical Trial Applications.
Point-of-Care Biopsy Market identifies market share by players along with the concentration rate using CR4, CR8 Index to determine leading and emerging competitive players such as Thermo Fisher Scientific (USA), Leica Biosystems (Germany), Hologic (USA), Becton Dickinson (USA), GE Healthcare (USA), Roche Diagnostics (Switzerland), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Qiagen (Germany), Agilent Technologies (USA), Danaher Corporation (USA), Sysmex Corporation (Japan), Bio-Rad Laboratories (USA), Bruker Corporation (USA), Illumina (USA).
The Global Point-of-Care Biopsy Market Study is Broken down by applications such as Cancer diagnosis, Infectious disease detection, Pathology, Personalized medicine, Surgical planning.
The Global Point-of-Care Biopsy Market Study is segmented by Needle biopsy, Core biopsy, Fine needle aspiration, Liquid biopsy, Image-guided biopsy.
The Global Point-of-Care Biopsy Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2020 - 2024; Base year: 2024; Forecast period: 2025 to 2032
Point-of-care biopsy refers to minimally invasive tissue sampling methods that can be performed rapidly near the patient site without need for centralized labs. Techniques include fine needle aspiration, core biopsy, and liquid biopsy. These allow faster diagnosis and treatment decisions especially in oncology and infectious diseases, improving patient outcomes and reducing hospital stay and costs. Advances in imaging and molecular analysis have expanded their utility and accuracy.
